GE HealthCare Technologies
75,13$
-1,37 (-1,79%)
11.07.2025, 23:30:55 Uhr
WKN: A3D3G6 ISIN: US36266G1076 Wertpapiertyp: Aktie Währung: US-Dollar
- 1T
- 1W
- 1M
- 3M
- 6M
- 1J
- 3J
- 5J
- 10J
- Max
Zuletzt angesehen
- Vont Transition... +2,87 +1,28% 227,82€
Kursperformance
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Tag | 75,13$ | -1,79% |
| 1 Woche | 76,07$ | -1,24% |
| 1 Monat | 73,40$ | +2,36% |
| 6 Monate | 84,68$ | -11,28% |
| Lfd. Jahr (YTD) | 78,11$ | -3,81% |
| 1 Jahr | 79,81$ | -5,86% |
| 3 Jahre | -- | -- |
| 5 Jahre | -- | -- |
Kursdaten
| Kurs | 75,13$ |
| Eröffnung | 75,67$ |
| Geld | 75,10$ |
| Brief | 76,50$ |
| Tages-Hoch | 75,86$ |
| Tages-Tief | 74,94$ |
| 52 Wochen-Hoch | 94,80$ |
| 52 Wochen-Tief | 57,65$ |
| Allzeit-Hoch | 94,80$ |
| Allzeit-Tief | 53,50$ |
Nachrichten
- BUSINESS WIRE: GE HealthCare Completes Acquisition of Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan - 31.03.2025, 08:02:03 Uhr
- BUSINESS WIRE: GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand - 31.01.2025, 09:00:01 Uhr
- BUSINESS WIRE: GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical - 02.12.2024, 05:45:26 Uhr
- BUSINESS WIRE: GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent - 07.10.2024, 08:30:06 Uhr
